Showing results (281-290 of 312) with videos related to
Sort By:
Pageof 32
Vaccine|August 15, 2021
Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedlesJordan A Stinson, Archana V Boopathy, Brian M Cieslewicz, et al.Antiviral Research|February 6, 2017
Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A virusesWenqian Tao, Brett L Hurst, Akhilesh Kumar Shakya, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 14, 2010
Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working GroupR Avery, H Clauss, L Danziger-Isakov, et al.Journal of Medical Internet Research|January 2, 2009
Rates and determinants of uptake and use of an internet physical activity and weight management program in office and manufacturing work sites in England: cohort studyLisa J Ware, Robert Hurling, Ogi Bataveljic, et al.Journal of the American Chemical Society|September 7, 2021
Trivalent Subunit Vaccine Candidates for COVID-19 and Their Delivery DevicesOscar A Ortega-Rivera, Matthew D Shin, Angela Chen, et al.Journal of Insect Science (Online)|April 12, 2026
An interdisciplinary approach to investigating an invasive insect pest: tracking, phenology, and genetics of the Queensland longhorn beetle, Acalolepta aesthetica (Cerambycidae: Lamiinae)Matthew S Siderhurst, Sheina B Sim, Jason D K Dzurisin, et al.ACS Medicinal Chemistry Letters|April 20, 2023
An Isomer of Galidesivir That Potently Inhibits Influenza Viruses and Members of the Bunyavirales OrderKevin J Sparrow, Rinu Shrestha, James M Wood, et al.Viruses|October 26, 2024
Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder LinesScott A Gibson, Yanan Liu, Rong Li, et al.Journal of Medical Virology|September 19, 2022
Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapyRuthMabel Boytz, Mikołaj Słabicki, Sita Ramaswamy, et al.Journal of Viral Hepatitis|August 16, 2024
Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic Hepatitis B-Related Hepatocellular CarcinomaY Sachar, S E Congly, K W Burak, et al.Pageof 32